| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |